The aim of this study was to report our early experience with (18)F-fluoride PET/CT for detecting lesions and evaluate the usefulness of this modality in the assessment of multiple myeloma (MM).(18)F-fluoride PET/CT and (99m)Tc-MDP bone scintigraphy (BS) studies from 7 myeloma patients (4 male and 3 female, mean age 55 years) diagnosed according to standard criteria were reviewed retrospectively. Two reviewers visually and quantitatively analyzed the images and recorded their findings after reaching a consensus. Diagnostic certainty regarding the presence or absence of myeloma lesions was evaluated according to the reference standard consisting of whole-body magnetic resonance imaging and whole-body X-ray.A total of 93 affected areas were definite according to the reference standard. Of these, 83 affected areas (89

作者：Yuji, Nishiyama；Ukihide, Tateishi；Kazuya, Shizukuishi；Ayako, Shishikura；Etsuko, Yamazaki；Hiroto, Shibata；Tomohiro, Yoneyama；Yoshiaki, Ishigatsubo；Tomio, Inoue

来源：Annals of nuclear medicine 2013 年 27卷 1期